(Q38243554)

31 August 2017

title

Promising Role of Melatonin as Neuroprotectant in Neurodegenerative Pathology (English)

1 reference

31 August 2017

0 references

1 reference

Neeraj Joshi

1

1 reference

31 August 2017

Joyshree Biswas

series ordinal

2

1 reference

31 August 2017

C Nath

series ordinal

3

1 reference

31 August 2017

Sarika Singh

series ordinal

4

1 reference

31 August 2017

publication date

27 August 2014

1 reference

31 August 2017

published in

Molecular Neurobiology

1 reference

31 August 2017

volume

52

1 reference

31 August 2017

issue

1

1 reference

31 August 2017

page(s)

330-340

1 reference

The basic physiology and pathophysiology of melatonin

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Melatonin: the chemical expression of darkness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

N-acetyltransferase is not the rate-limiting enzyme of melatonin synthesis at night

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Evidence for melatonin synthesis in mouse and human bone marrow cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

The immunotherapeutic potential of melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Extrapineal melatonin: analysis of its subcellular distribution and daily fluctuations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Daily and annual rhythms in human melatonin secretion: role in puberty control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Melatonin: clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Melatonin--a pleiotropic, orchestrating regulator molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Functional MT1 and MT2 melatonin receptors in mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Melatonin receptors: localization, molecular pharmacology and physiological significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melatonin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Melatonin receptor subtype expression in human cerebellum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Increased melatonin 1a-receptor immunoreactivity in the hippocampus of Alzheimer's disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Melatonin, melatonin receptors and melanophores: a moving story

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Evidence that membrane-bound G protein-coupled melatonin receptors MT1 and MT2 are not involved in the neuroprotective effects of melatonin in focal cerebral ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Melatonin receptors and their regulation: biochemical and structural mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Melatonin mt1 and MT2 receptors stimulate c-Jun N-terminal kinase via pertussis toxin-sensitive and -insensitive G proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

The modulation of neuronal activity by melatonin: in vitro studies on mouse hippocampal slices

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Melatonin receptors in rat hippocampus: molecular and functional investigations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Reduced hippocampal MT2 melatonin receptor expression in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

MT2 melatonin receptor immunoreactivity in neurons is very high in the aged hippocampal formation in gerbils

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Decreased MT1 and MT2 melatonin receptor expression in extrapineal tissues of the rat during physiological aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

The MT2 melatonin receptor subtype is present in human retina and decreases in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

The melatonin MT1 receptor axis modulates mutant Huntingtin-mediated toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Melatonin inhibits the caspase-1/cytochrome c/caspase-3 cell death pathway, inhibits MT1 receptor loss and delays disease progression in a mouse model of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

NF-kappaB activation by reactive oxygen species: fifteen years later

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Reactive oxygen species stimulates receptor activator of NF-kappaB ligand expression in osteoblast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Reactive oxygen species, cellular redox systems, and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Melatonin, hydroxyl radical-mediated oxidative damage, and aging: a hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Antioxidant properties of melatonin--an emerging mystery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Potent protective effect of melatonin on chromium(VI)-induced DNA single-strand breaks, cytotoxicity, and lipid peroxidation in primary cultures of rat hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Melatonin: a peroxyl radical scavenger more effective than vitamin E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Dietary supplementation with melatonin reduces levels of amyloid beta-peptides in the murine cerebral cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Clinical uses of melatonin: evaluation of human trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Spontaneous central melatonin secretion and resorption kinetics of exogenous melatonin: a ventricular CSF study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Evaluation of the antioxidant activity of melatonin in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Melatonin protects neurons from singlet oxygen-induced apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Exploratory laser flash photolysis study of free radical reactions and magnetic field effects in melatonin chemistry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Dietary modulation of age-related changes in cerebral pro-oxidant status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Melatonin cytotoxicity in human leukemia cells: relation with its pro-oxidant effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Evidence of prooxidant and antioxidant action of melatonin on human liver cell line HepG2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Intracellular prooxidant activity of melatonin induces a survival pathway involving NF-kappaB activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Melatonin enhances hydrogen peroxide-induced apoptosis in human promyelocytic leukaemia HL-60 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Melatonin in cancer management: progress and promise

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Fas/Fas ligand regulation mediates cell death in human Ewing's sarcoma cells treated with melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Mechanisms involved in the pro-apoptotic effect of melatonin in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Melatonin is a scavenger of peroxynitrite

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

On the free radical scavenging activities of melatonin's metabolites, AFMK and AMK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Regulation of antioxidant enzymes: a significant role for melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Melatonin ameliorates endothelial dysfunction, vascular inflammation, and systemic hypertension in rats with chronic intermittent hypoxia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Melatonin ameliorates injury and specific responses of ischemic striatal neurons in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

New agents promote neuroprotection in Parkinson's disease models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Melatonin ameliorates cognitive impairment induced by sleep deprivation in rats: role of oxidative stress, BDNF and CaMKII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Biochemical and genetic alterations of oxidant/antioxidant status of the brain in rats treated with dexamethasone: protective roles of melatonin and acetyl-L-carnitine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Fish oil, melatonin and vitamin E attenuates midbrain cyclooxygenase-2 activity and oxidative stress after the administration of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Melatonin attenuates dexamethasone toxicity-induced oxidative stress, calpain and caspase activation in human neuroblastoma SH-SY5Y cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Apoptotic neuronal death in Parkinson's disease: involvement of nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Early melatonin supplementation alleviates oxidative stress in a transgenic mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Melatonin attenuates amyloid beta25-35-induced apoptosis in mouse microglial BV2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Melatonin alleviates behavioral deficits associated with apoptosis and cholinergic system dysfunction in the APP 695 transgenic mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Effects of melatonin on wortmannin-induced tau hyperphosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Astrocyte activation: a key step in rotenone induced cytotoxicity and DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

A study to correlate rotenone induced biochemical changes and cerebral damage in brain areas with neuromuscular coordination in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Melatonin-enhanced autophagy protects against neural apoptosis via a mitochondrial pathway in early brain injury following a subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Melatonin alters cell death processes in response to age-related oxidative stress in the brain of senescence-accelerated mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Antioxidant neuroprotection against ethanol-induced apoptosis in HN2-5 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Melatonin Induces Akt Phosphorylation through Melatonin Receptor- and PI3K-Dependent Pathways in Primary Astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Sustained activation of Akt by melatonin contributes to the protection against kainic acid-induced neuronal death in hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Melatonin inhibits cholangiocarcinoma and reduces liver injury in Opisthorchis viverrini-infected and N-nitrosodimethylamine-treated hamsters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Protective effect of melatonin on bone marrow mesenchymal stem cells against hydrogen peroxide-induced apoptosis in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

The neuroprotective effect of melatonin against the induction of c-Jun phosphorylation by 6-hydroxydopamine on SK-N-SH cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Melatonin inhibits MPP+-induced caspase-mediated death pathway and DNA fragmentation factor-45 cleavage in SK-N-SH cultured cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Growth hormone and melatonin prevent age-related alteration in apoptosis processes in the dentate gyrus of male rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Melatonin premedication attenuates isoflurane anesthesia-induced β-amyloid generation and cholinergic dysfunction in the hippocampus of aged rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Melatonin attenuates polychlorinated biphenyls induced apoptosis in the neuronal cells of cerebral cortex and cerebellum of adult male rats--in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Apoptosis and autophagy: regulatory connections between two supposedly different processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Role of the Crosstalk between Autophagy and Apoptosis in Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Melatonin attenuates kainic acid-induced neurotoxicity in mouse hippocampus via inhibition of autophagy and α-synuclein aggregation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Inhibition of autophagy contributes to melatonin-mediated neuroprotection against transient focal cerebral ischemia in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Melatonin treatment for age-related insomnia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

The efficacy and safety of exogenous melatonin for primary sleep disorders. A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Melatonin in perioperative medicine: Current perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Pineal calcification in Alzheimer's disease: an in vivo study using computed tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Melatonin impairs NADPH oxidase assembly and decreases superoxide anion production in microglia exposed to amyloid-beta1-42

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Novel mechanisms and approaches in the study of neurodegeneration and neuroprotection. a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Effect of melatonin on calyculin A-induced tau hyperphosphorylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Melatonin suppresses macrophage cyclooxygenase-2 and inducible nitric oxide synthase expression by inhibiting p52 acetylation and binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

An assessment of the antioxidant and the antiamyloidogenic properties of melatonin: implications for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Anti-inflammatory effect of melatonin on A beta vaccination in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Melatonin plus physical exercise are highly neuroprotective in the 3xTg-AD mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Melatonin effects on sleep, mood, and cognition in elderly with mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Possible therapeutic value of melatonin in mild cognitive impairment: a retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Increased melatonin may play dual roles in the striata of a 6-hydroxydopamine model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Therapeutic applications of melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Targeting programmed cell death in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Involvement of nitric oxide in neurodegeneration: a study on the experimental models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Involvement of the mitochondrial apoptotic pathway and nitric oxide synthase in dopaminergic neuronal death induced by 6-hydroxydopamine and lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Inhibition of the cdk5/p25 fragment formation may explain the antiapoptotic effects of melatonin in an experimental model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Melatonin in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson's disease. A randomized, double blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Neuroscience: breaking down scientific barriers to the study of brain and mind

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Oxidative damage in Huntington's disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Huntingtin's neuroprotective activity occurs via inhibition of procaspase-9 processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Methazolamide and melatonin inhibit mitochondrial cytochrome C release and are neuroprotective in experimental models of ischemic injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Constitutively active TRPC3 channels regulate basal ganglia output neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Protective effect of melatonin on 3-nitropropionic acid-induced oxidative stress in synaptosomes in an animal model of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Melatonin reduces quinolinic acid-induced lipid peroxidation in rat brain homogenate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Blood 5-hydroxytryptamine, 5-hydroxyindoleacetic acid and melatonin levels in patients with either Huntington's disease or chronic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Delayed onset of the diurnal melatonin rise in patients with Huntington's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Apoptosis and caspases in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Programmed cell death in amyotrophic lateral sclerosis: a mechanism of pathogenic and therapeutic importance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Characterization of the caspase cascade in a cell culture model of SOD1-related familial amyotrophic lateral sclerosis: expression, activation and therapeutic effects of inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Sodium phenylbutyrate prolongs survival and regulates expression of anti-apoptotic genes in transgenic amyotrophic lateral sclerosis mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Reduced oxidative damage in ALS by high-dose enteral melatonin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Decreasing glutamate buffering capacity triggers oxidative stress and neuropil degeneration in the Drosophila brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Melatonin as a candidate compound for neuroprotection in amyotrophic lateral sclerosis (ALS): high tolerability of daily oral melatonin administration in ALS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Overexpression of melatonin membrane receptors increases calcium-binding proteins and protects VSC4.1 motoneurons from glutamate toxicity through multiple mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

Drug insight: cancer therapy strategies based on restoration of endogenous cell death mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8865-8

[Sleep disorders in Parkinson's disease without dementia: a comparative randomized controlled study of melatonin and clonazepam]

21 January 2018

1 reference

12 December 2020

Cardiovascular diseases: protective effects of melatonin

1 reference

12 December 2020

Melatonin is an efficient antioxidant

1 reference

12 December 2020

Safety in melatonin use

1 reference

12 December 2020

Mechanisms of trazodone-induced cytotoxicity and the protective effects of melatonin and/or taurine toward freshly isolated rat hepatocytes

1 reference

12 December 2020

Serum and cerebrospinal fluid concentrations of melatonin: a pilot study in healthy male volunteers

1 reference

12 December 2020

Malondialdehyde, superoxide dismutase, melatonin, iron, copper, and zinc blood concentrations in patients with Alzheimer disease: cross-sectional study

1 reference

12 December 2020

Melatonin attenuates hippocampal neuron apoptosis and oxidative stress during chronic intermittent hypoxia via up-regulating B-cell lymphoma-2 and down-regulating B-cell lymphoma-2-associated X protein

1 reference

12 December 2020

Mitochondrial dysfunction in movement disorders.

1 reference

12 December 2020

Decreased melatonin levels in postmortem cerebrospinal fluid in relation to aging, Alzheimer's disease, and apolipoprotein E-epsilon4/4 genotype

1 reference

12 December 2020

Identification and characterization of 2[125I]-iodomelatonin binding sites in the rat epididymis

1 reference

12 December 2020

Melatonin reduces H2O2-induced lipid peroxidation in homogenates of different rat brain regions

1 reference

12 December 2020

Melatonin MT1 and MT2 receptor expression in Parkinson's disease

1 reference

12 December 2020

Safety and efficacy of melatonin in pediatric migraine prophylaxis.

1 reference

12 December 2020

Melatonin prevents dopaminergic cell loss induced by lentiviral vectors expressing A30P mutant alpha-synuclein.

1 reference

12 December 2020

Scavenging of reactive oxygen species by melatonin

1 reference

12 December 2020

Melatonin's protective action against ischemic neuronal damage is associated with up-regulation of the MT2 melatonin receptor

1 reference

12 December 2020

Role of melatonin in cancer treatment.

1 reference

12 December 2020

Reaction of peroxynitrite with melatonin: A mechanistic study

1 reference

12 December 2020

Wild-type huntingtin protects from apoptosis upstream of caspase-3.

1 reference

12 December 2020

Alloxan acts as a prooxidant only under reducing conditions: influence of melatonin

1 reference

12 December 2020

Role of melatonin in reduction of lipid peroxidation and peroxynitrite formation in non-septic shock induced by zymosan

1 reference

12 December 2020

Melatonin involvement in oxidative processes

1 reference

12 December 2020

Melatonin and tryptophan derivatives as free radical scavengers and antioxidants

1 reference

12 December 2020

Melatonin prevents death of neuroblastoma cells exposed to the Alzheimer amyloid peptide.

1 reference

12 December 2020

Therapeutic application of melatonin in mild cognitive impairment.

1 reference

12 December 2020

Inhibitors of cytochrome c release with therapeutic potential for Huntington's disease

1 reference

12 December 2020

Prevention of isoproterenol-induced tau hyperphosphorylation by melatonin in the rat.

1 reference

12 December 2020

Prevalence of Parkinson's disease in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group

1 reference

12 December 2020

[The use of melatonin in the treatment of chronic fatigue syndrome and circadian rhythm disorders in Parkinson's disease]

1 reference

12 December 2020

Pineal and cortical melatonin receptors MT1 and MT2 are decreased in Alzheimer's disease.

1 reference

12 December 2020

10.1007/S12035-014-8865-8

Identifiers

DOI

1 reference

Dimensions Publication ID

31 August 2017

1030787836

0 references

1 reference